ReVision now anticipates initiating early-stage human clinical trials of its Occular BCI in blind volunteers in 2027.

The 2020 "Lizzie McGuire" reboot got canned pretty quickly ... but we may be getting another one -- in about 20 years! The ...

ReVision Implant announced today that it received FDA breakthrough device designation for its Occular visual cortical prosthesis.

Some ASX shares have the same characteristics Warren Buffett often looks for in long-term investments. The post 3 ...

Surgeons from the American Academy of Otolaryngology–Head and Neck Surgery will meet with lawmakers on Capitol Hill March 11 to advocate for policies aimed at protecting patient access to care. The ...